Deschamps Lisa's Form 4 filing
Verona Pharma plc (VRNA) · filed Nov 3, 2021
- Accession no.
- 0001104659-21-133859
- Filed
- Nov 3, 2021
- Trade date
- Nov 2, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $7.70K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Deschamps LisaCIK 0001847538 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2021 | Ordinary Shares | SSaleDisposed | −11,672 | $0.66F3 | −$7,703.52 | 81,984 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported represents the sale price of the Issuer's ADSs divided by eight (8).
Referenced by the price of 1 transaction in Table I.